Possible Effect of 5, 6- Dimethyl -4 Isothiocyanate Thieno [2, 3-d] Pyrimidine and I or Irradiation on Ehrlich Carcinoma in Mice

Considerable attention has been devoted to the construction of new derivatives of [2,3-d] pyrimidines on the account of their reported biological activities. The aim of the present work is to evaluate the antitumour activity of 5, 6- dimethyl -4- isothiocyanate- thieno [2,3-d] pyrimidine (DMITCTP) in solid Ehrlich carcinoma (SEC) bearing mice. DMITCTP was administered on the 10th day after tumor inoculation at a dose of 150 mg/kg BW, day after day, during a period of 3 weeks. Whole body exposure to one dose of 2Gy gamma irradiation was carried out two weeks after DMITCTP administration. Biochemical analysis in the blood of solid Ehrlich carcinoma (SEC) bearing mice showed significant increase in MDA content and GSH-Px activity level a significant decrease in GSH content and SOD activity level, IL 10 concentration and TNF- α concentration was detected associated with significant alteration in kidney and liver functions, as compared to control. Administration of DMITCTP alone or in combination with gamma-irradiation has significantly decrease MDA content and GSH-Px activity level associated with significant increase in GSH content, SOD activity level, IL-10 concentration and TNF-a concentration, compared to SEC bearing mice. These results supported by significant improvement in liver and kidney functions. Treatment solid Ehrlich carcinoma (SEC) bearing mice with gamma-irradiation or DMITCTP combined with y-irradiation showed significant increase in MDA content, GSH-Px and GST activities levels and in amount of metabolites of CYP450 and significant decrease in GSH content, and SOD activity level, as compared to SEC bearing mice. Administration of DMITCTP alone or combined with gamma- irradiation has significantly decreased tumor volume